These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
79 related items for PubMed ID: 6110223
1. [Incidence of tardive dyskinesia and its characteristics in a psychiatric hospital in our milieu]. Moura DS, Karniol IG. AMB Rev Assoc Med Bras; 1980 Jun; 26(6):197-200. PubMed ID: 6110223 [No Abstract] [Full Text] [Related]
3. Comparison of severe and mild tardive dyskinesia: implications for etiology. Gardos G, Cole JO, Schniebolk S, Salomon M. J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550 [Abstract] [Full Text] [Related]
4. [Tardive dyskinesia in Spain]. Bermejo F, del Ser T, Calandre L. Med Clin (Barc); 1985 Jun 15; 85(3):125. PubMed ID: 2862312 [No Abstract] [Full Text] [Related]
5. [Occurrence of tardive dyskinesia during neuroleptic treatment]. Fanget F, Henry E, Aimard G. Presse Med; 1986 Dec 06; 15(43):2147-50. PubMed ID: 2884657 [Abstract] [Full Text] [Related]
6. Drug therapy of tardive dyskinesia. Kobayashi RM. N Engl J Med; 1977 Feb 03; 296(5):257-60. PubMed ID: 12469 [No Abstract] [Full Text] [Related]
7. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables. Ezrin-Waters C, Seeman MV, Seeman P. J Clin Psychiatry; 1981 Jan 03; 42(1):16-22. PubMed ID: 6109715 [Abstract] [Full Text] [Related]
8. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. Kane JM. J Clin Psychiatry; 2004 Jan 03; 65 Suppl 9():16-20. PubMed ID: 15189107 [Abstract] [Full Text] [Related]
9. Tardive dyskinesia: epidemiologic factors as a guide for prevention and management. Casey DE. Adv Biochem Psychopharmacol; 1985 Jan 03; 40():15-24. PubMed ID: 2862762 [No Abstract] [Full Text] [Related]
10. Tardive dystonia: four case histories. Yadalam KG, Korn ML, Simpson GM. J Clin Psychiatry; 1990 Jan 03; 51(1):17-20. PubMed ID: 1967246 [Abstract] [Full Text] [Related]
11. Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia. Souza RP, Remington G, Meltzer HY, Lieberman JA, Kennedy JL, Wong AH. Int Clin Psychopharmacol; 2010 Sep 03; 25(5):264-9. PubMed ID: 20436352 [Abstract] [Full Text] [Related]
12. Vulnerability to tardive dyskinesia. Wolf ME, DeWolfe AS, Ryan JJ, Lips O, Mosnaim AD. J Clin Psychiatry; 1985 Sep 03; 46(9):367-8. PubMed ID: 2863257 [Abstract] [Full Text] [Related]
13. Tardive dyskinesia in chronic schizophrenic inpatients. Kua EH, Ang PC, Siew HC. Singapore Med J; 1982 Feb 03; 23(1):19-21. PubMed ID: 6126008 [No Abstract] [Full Text] [Related]
14. Patterns of psychotropic drug use and tardive dyskinesia. Branchey M, Branchey L. J Clin Psychopharmacol; 1984 Feb 03; 4(1):41-5. PubMed ID: 6141189 [Abstract] [Full Text] [Related]
15. Tardive dyskinesia. McAfee HA. Am J Nurs; 1978 Mar 03; 78(3):359-7. PubMed ID: 25020 [No Abstract] [Full Text] [Related]
16. Swallowing, tardive dyskinesia and anticholinergics. Craig TJ, Richardson MA. Am J Psychiatry; 1982 Aug 03; 139(8):1083. PubMed ID: 6124138 [No Abstract] [Full Text] [Related]
17. Tardive dyskinesia and anticholinergic drugs. A critical review of the literature. Yassa R. Encephale; 1988 Sep 03; 14 Spec No():233-9. PubMed ID: 3063514 [Abstract] [Full Text] [Related]
18. Tardive dyskinesia and anticholinergic drugs. Gardos G, Cole JO. Am J Psychiatry; 1983 Feb 03; 140(2):200-2. PubMed ID: 6129809 [Abstract] [Full Text] [Related]
19. The prevalence of tardive dyskinesia. Woerner MG, Kane JM, Lieberman JA, Alvir J, Bergmann KJ, Borenstein M, Schooler NR, Mukherjee S, Rotrosen J, Rubinstein M. J Clin Psychopharmacol; 1991 Feb 03; 11(1):34-42. PubMed ID: 1674949 [Abstract] [Full Text] [Related]
20. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics. Glazer WM. J Clin Psychiatry; 2000 Feb 03; 61 Suppl 4():15-20. PubMed ID: 10739326 [Abstract] [Full Text] [Related] Page: [Next] [New Search]